Laser Photonics Corp (LASE): Nasdaq/NYSE listing notice — Laser Photonics receives Nasdaq deficiency notice for audit committee non-compliance after director resignation

Laser Photonics Corp

Nasdaq notice dated Feb 17, 2023 cites non-compliance with Listing Rule 5605 after Glenn Peterson resigned from board and audit committee on Dec 16, 2022.
Cure period: until earlier of next annual shareholders' meeting or Dec 16, 2023; if meeting before June 14, 2023, compliance due by June 14, 2023.
Company is evaluating candidates to fill the audit committee vacancy and regain compliance.
Failure to cure could result in delisting from Nasdaq.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Laser Photonics Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605, 5605(c)(4)

Exact text from the filing

February 17, 2023, the registrant (“Laser Photonics” or the “Company”) received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company no longer complies with Nasdaq’s audit committee requirement under Nasdaq’s Listing Rule 5605 following the resignation of Glenn Peterson from the Company’s board of directors and audit committee effective December 16, 2022. Nasdaq advised Laser Photonics that in accordance with Nasdaq’s Listing Rule 5605(c)(4) the Company has a cure period to regain compliance (i) until the earlier of the Compa

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Laser Photonics Corp filing history →

Source: SEC EDGAR

accession 0001654954-23-002071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.